Clinical Data Disclosure: The Complicated Efforts to Make Research Transparent

Continuing efforts to increase visibility into the clinical trial process have resulted in a number of proposed and final regulations, guidance documents, and principles for the sharing of both study-level and patient-level clinical data. In this webinar, industry leaders will review the current content and status of the different requirements and recommendations for data-sharing from the EMEA, FDA and PhRMA. This review will assist attendees in determining the necessary steps to navigate through the complicated field of data transparency and to assure compliance.